Evidence map›Paper›PMID 26525962›Full record

Trial reportBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals2015

Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect.

Michael W Ogden, Kristin M Marano, Bobbette A Jones, Walter T Morgan, Mitchell F Stiles

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02061917 (Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus - A Multi-center Evaluation of Health-related Quality of Life Assessments and Biomarkers of Exposure and Harm), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02061917 nacompletednot on this map

Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus - A Multi-center Evaluation of Health-related Quality of Life Assessments and Biomarkers of Exposure and Harm

TypeinterventionalSponsorR.J. Reynolds Tobacco CompanyRan2007 to 2009Enrolled163ConditionsCigarette SmokingArmsTobacco-Heating Cigarette, Snus (Smokeless Tobacco), Tobacco-Burning Cigarette
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Exposure to Heated Tobacco Products and Adverse Health Effects, a Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  3. Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2015
    Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael W Ogdena RAI Services Company , Winston-Salem, NC , USA and.
Kristin M Maranoa RAI Services Company , Winston-Salem, NC , USA and.
Bobbette A Jonesb R.J. Reynolds Tobacco Company , Winston-Salem, NC , USA.
Walter T Morganb R.J. Reynolds Tobacco Company , Winston-Salem, NC , USA.
Mitchell F Stilesb R.J. Reynolds Tobacco Company , Winston-Salem, NC , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A randomized, multi-center study of adult cigarette smokers switched to tobacco-heating cigarettes, snus or ultra-low machine yield tobacco-burning cigarettes (50/group) for 24 weeks was conducted. Evaluation of biomarkers of biological effect (e.g. inflammation, lipids, hypercoaguable state) indicated that the majority of consistent and statistically significant improvements over time within each group were observed in markers of inflammation. Consistent and statistically significant differences in pairwise comparisons between product groups were not observed. These findings are relevant to the understanding of biomarkers of biological effect related to cigarette smoking as well as the risk continuum across various tobacco products (ClinicalTrials.gov Identifier: NCT02061917).

Indexed as

Smoking PreventionAdultBiomarkersFemaleHumansInflammation MediatorsLipidsMaleMiddle AgedTime FactorsTobacco, SmokelessTobacco Use CessationTobacco Use Cessation DevicesBiomarkersInflammation MediatorsLipidsInflammationmulti-center randomized studyoxidative stressrisk continuum

Identifiers

PMID26525962
PMCPMC4720037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.